Size-Dependent Target Engagement of Covalent Probes

Labeling proteins with covalent ligands is finding increasing use in proteomics applications, including identifying nucleophilic residues amenable for labeling and in the development of targeted covalent inhibitors (TCIs). Labeling efficiency is measured by the covalent occupancy of the target or by biochemical activity. Here, we investigate how these observed quantities relate to the intrinsic parameters of complex formation, namely, noncovalent affinity and covalent reactivity, and to experimental conditions, including incubation time and ligand concentration. It is shown that target engagement is beneficially driven by noncovalent recognition for lead-like compounds, which are appropriate starting points for targeted covalent inhibitors owing to their easily detectable occupancy and fixed binding mode, facilitating optimization. In contrast, labeling by fragment-sized compounds is inevitably reactivity-driven as their small size limits noncovalent affinity. They are well-suited for exploring ligandable nucleophilic residues, while small fragments are less appropriate starting points for TCI development.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-03-18
DOI
https://doi.org/10.1021/acs.jmedchem.5c00017
Citations
5
Primary Topic
Click Chemistry and Applications
Type
article
Field-Weighted Citation Impact
4.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Size-Dependent Target Engagement of Covalent Probes

Péter Ábrányi‐Balogh, Attila Egyed, György M. Keserű, Ronen Gabizon et al.
5 citations
Journal of Medicinal Chemistry
Click Chemistry and Applications
4.68
article

Size-Dependent Target Engagement of Covalent Probes

Péter Ábrányi‐Balogh, Attila Egyed, György M. Keserű, Ronen Gabizon, Nikolett Péczka, László Petri, Tamás Takács, György G. Ferenczy
article en
5 citations

Abstract

Labeling proteins with covalent ligands is finding increasing use in proteomics applications, including identifying nucleophilic residues amenable for labeling and in the development of targeted covalent inhibitors (TCIs). Labeling efficiency is measured by the covalent occupancy of the target or by biochemical activity. Here, we investigate how these observed quantities relate to the intrinsic parameters of complex formation, namely, noncovalent affinity and covalent reactivity, and to experimental conditions, including incubation time and ligand concentration. It is shown that target engagement is beneficially driven by noncovalent recognition for lead-like compounds, which are appropriate starting points for targeted covalent inhibitors owing to their easily detectable occupancy and fixed binding mode, facilitating optimization. In contrast, labeling by fragment-sized compounds is inevitably reactivity-driven as their small size limits noncovalent affinity. They are well-suited for exploring ligandable nucleophilic residues, while small fragments are less appropriate starting points for TCI development.

Journal of Medicinal ChemistryVol. 68(6)
Eötvös Loránd University (HU), Budapest University of Technology and Economics (HU), Weizmann Institute of Science (IL), HUN-REN Research Centre for Natural Sciences (HU)
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Climate action
Openalex Percentile: Top 6%
Click Chemistry and Applications
4.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.